NetworkNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.’s Proprietary Technology Levels Field with...
23 1월 2019 - 10:30PM
via NetworkWire – NetworkNewsAudio announces the Audio Press
Release (APR) titled “Definitive Agreement Marks Milestone for
Alternative Nicotine Delivery Options,” featuring Lexaria
Bioscience Corp. (CSE:LXX) (OTCQX:LXRP).
To hear the NetworkNewsAudio version, visit:
http://nnw.fm/Kft8h
To read the full editorial, visit: http://nnw.fm/xbD2Z
The answer lies in Lexaria’s proprietary DehydraTECH technology.
This technology has already demonstrated its ability to mask
unpleasant flavors and speed up delivery of orally ingested
nicotine in successful previous animal studies. Imagine the
possibility of satisfying a nicotine craving in something as simple
and unobtrusive as a cup of coffee.
“Lexaria Bioscience has repeatedly demonstrated the powerful
effects of its patented DehydraTECH technology for enhancing the
palatability and speed of onset of orally consumed bioactive
substances such as nicotine,” said John Docherty, president of
Lexaria Bioscience. “Laboratory research to date on oral nicotine
formulations has been quite encouraging. We are very excited to
advance the clinical phases of our comprehensive R&D program
together with [one of the world’s largest tobacco companies] with a
view to full commercial product development.”
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its
disruptive delivery technology that promotes healthier ingestion
methods, lower overall dosing and quicker onset of lipophilic
active molecules. Lexaria has ten patents granted in the USA and in
Australia and has filed over 50 patent applications worldwide
across ten patent families. Lexaria’s technology provides more
rapid delivery to the bloodstream; and important taste-masking
benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs
(NSAIDs), nicotine and other molecules. Lexaria Nicotine LLC is a
United States domiciled, majority-owned subsidiary of Lexaria
Bioscience Corp., focused on reduced-risk nicotine solutions
www.LexariaNicotineco.com. For more information, visit the
company’s website at www.LexariaBioscience.com.
About NetworkNewsAudio
NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution, allows
you to sit back and listen to market updates, CEO interviews and a
Company AudioPressRelease (APR). These audio clips provide
snapshots of position, opportunity and
momentum. NetworkNewsAudio (NNA) can assist your company
by cutting through the overload of information in today's market,
NNA brings its clients unparalleled visibility, recognition and
brand awareness. NetworkNewsWire (NNW) is where news,
content and information converge. NetworkNewsWire
(NNW) is a comprehensive provider of news aggregation and
syndication, enhanced press release services and a full array of
social communication solutions. As a multifaceted financial news
and distribution company with an extensive team of journalists and
writers, NNW has the unparalleled ability to reach a wide audience
of investors, consumers, journalists and the general public with an
ever-growing distribution network of more than 5,000 key
syndication outlets across the nation.
For more information, visit: www.NetworkNewsAudio.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer.
Forward-Looking Statements
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
Corporate Communications Contact:
NetworkNewsWire (NNW) New York, New York
www.NetworkNewsWire.com 212.418.1217 Office
Editor@NetworkNewsWire.com
Lexaria Bioscience (CSE:LXX)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Lexaria Bioscience (CSE:LXX)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025